Expected earnings - Renalytix plc
Source: US Earnings Reports
Renalytix plc (RNLXY) is expected to report for Q2 2025
Renalytix plc
NASDAQ: RNLXY
RNLXY Trading
0.35% G/L:
$1.70 Last:
100 Volume:
$1.70 Open:
RNLXY Latest News
November 18, 2025 07:51:00 am
Pivotal kidneyintelX.dkd Data Published in Diabetes Care, Considered the Leading Clinical Journal Worldwide in Diabetes
September 15, 2025 08:00:00 am
Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease
July 21, 2025 07:00:00 am
MVP Health Care and Renalytix Partner to Bring Life-Changing Kidney Disease Testing to Local Communities
RNLXY Stock Data
$34,786,689
8,652,970
19.74%
3
378915%
Healthcare Providers & Services
Healthcare
GB
London
